Abbott boosts generic drug sales by 31% in strong Q2 showing

Give a whoop for Abbott Laboratories' ($ABT) buyout of CFR Pharmaceuticals. That deal helped boost the company's generics sales for the second quarter to $977 million, up by 31%. The generics unit now accounts for 21% of Abbott's overall sales. Report